Nuvasive Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 23.09
Dividend & YieldN/A$ (N/A)
Beta 1.06
Market capitalization 1.94B
Operating cash flow 159.75M
ESG Scores unknown

Company description

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio2.42
Working Capital-0.11
Return On Equity-0.08
Debt To Equity1.11
Fixed Asset Ratio0.12
Fixed Interest Cover2.69

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 22.9M -3.92M 8.76M 533k
Total Cashflows From Investing Activities -161.28M -134.48M -281.93M -136.06M
Net Borrowings 873.85M 873.85M 873.85M -649.43M
Total Cash From Financing Activities -14.58M -6.64M 736.66M -653.35M
Change To Operating Activities 1.31M 19.63M -28.64M 766k
Issuance Of Stock 8.13M 6.42M 6.17M 6.22M
Net Income 12.48M 65.23M -37.15M -64.09M
Change In Cash 42.04M 94.29M 643.84M -610.78M
Effect Of Exchange Rate -1.28M 131k 3.2M -3.54M
Total Cash From Operating Activities 219.18M 235.29M 185.91M 182.17M
Depreciation 119.17M 125.19M 130.54M 137.32M
Change To Account Receivables 4.56M -16.41M 3.03M -11.69M
Other Cashflows From Financing Activities -19.78M 1.42M -62.7M -1.33M
Change To Netincome 64.63M 64.94M 84.5M 137.41M
Capital Expenditures -101.92M -122.88M -105.73M -111.11M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 61.7M 72.38M 79.84M 92.63M
Income Before Tax 8.72M 80.52M -47.55M -58.38M
Net Income 12.48M 65.23M -37.15M -64.09M
Selling General Administrative 575.84M 611.18M 547.2M 610.09M
Gross Profit 790.55M 855.71M 728.95M 816.71M
Ebit 102.35M 121.06M 50.19M 56.69M
Operating Income 102.35M 121.06M 50.19M 56.69M
Interest Expense -37.86M -38.52M -70.47M -21.06M
Income Tax Expense -3.76M 15.28M -10.39M 5.7M
Total Revenue 1.1B 1.17B 1.05B 1.14B
Cost Of Revenue 311.16M 312.36M 321.63M 322.28M
Total Other Income ExpenseNet -93.63M -40.54M -97.74M -115.07M
Net Income From Continuing Ops 12.48M 65.23M -37.15M -64.09M
Net Income Applicable To Common Shares 12.48M 65.23M -37.15M -64.09M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 873.33M 970.08M 1.77B 1.36B
Total Stockholder Equity 834.52M 915.21M 918.92M 795.21M
Other Current Liabilities 15.14M 19.75M 15.76M 12.09M
Total Assets 1.71B 1.89B 2.69B 2.15B
Common Stock 61k 62k 62k 63k
Other Current Assets 16.91M 10.43M 4.73M 5.42M
Retained Earnings 17.24M 82.47M 45.32M 45.71M
Treasury Stock -580.61M -597.18M -676.47M -685.54M
Cash 117.84M 213.03M 856.87M 246.09M
Total Current Liabilities 179.46M 206.92M 836.36M 200.89M
Other Stockholder Equity -8.63M -9.42M -7.58M -7.79M
Property, Plant, and Equipment 238.84M 333.25M 388.64M 406.65M
Total Current Assets 618.21M 764.34M 1.56B 802.42M
Net Tangible Assets 21.11M 153.05M 207.1M -80.94M
Net Receivables 196.49M 211.53M 207.07M 214.4M
Accounts Payable 8.8M 11.83M 17.39M 16.19M


Insider Transactions

Here are the insider transactions of stock shares related to Nuvasive Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NORWALK LESLIE VD2022-06-01Director1.55k
KADIA SIDDHARTHAD2022-05-27Director3.74k
ROSENBERG DONALD J. ESQ.I2022-05-11Director13.33k
BARRY JAMES CHRISTOPHERSale at price 58.00 per share.D2022-04-13Chief Executive Officer5k
BARRY JAMES CHRISTOPHERSale at price 55.00 per share.D2022-03-28Chief Executive Officer5k
SISITSKY NATHANIEL BD2022-03-01General Counsel8.03k
BARRY JAMES CHRISTOPHERD2022-03-01Chief Executive Officer53.52k
WOLF DALE AD2022-03-01Officer4.01k
CALAFIORE MASSIMOD2022-03-01Officer8.7k
BARRY JAMES CHRISTOPHERD2021-11-05Chief Executive Officer29.9k
WOLF DALE AD2021-09-01Officer4.26k
CALAFIORE MASSIMOD2021-09-01Officer1.42k
BARRY JAMES CHRISTOPHERSale at price 70.00 per share.D2021-06-25Chief Executive Officer5k
BARRY JAMES CHRISTOPHERSale at price 68.00 per share.D2021-06-21Chief Executive Officer5k
NORWALK LESLIE VD2021-06-01Director1.55k
LUCIER GREGORY TI2021-05-18Director19.12k
VITALE LUCASSale at price 68.23 per share.D2021-05-07Officer2.21k
CALAFIORE MASSIMOSale at price 68.23 per share.D2021-05-07Officer3.4k
LUCIER GREGORY TI2021-04-30Director42.57k
SISITSKY NATHANIEL BD2021-04-30General Counsel2.49k
VITALE LUCASD2021-04-30Officer3.38k
CALAFIORE MASSIMOD2021-04-30Officer5.19k
VITALE LUCASSale at price 68.19 per share.D2021-04-12Officer4.31k
CALAFIORE MASSIMOSale at price 68.19 per share.D2021-04-12Officer3.5k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Nuvasive Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Nuvasive Inc

Here is the result of two systematic investment strategies applied to Nuvasive Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Nuvasive Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Nuvasive Inc:

Nuvasive Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 8.29% on the backtest period.

Performance at glance

Performance

8.29 %

Latent gain

188.54 $

Invested capital

2274.7 $

Annualized return

2.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Nuvasive Inc

This is the result of two momentum investment strategies applied to Nuvasive Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Nuvasive Inc

The following chart shows all the entries opened by the momentum investment system on Nuvasive Inc:

Nuvasive Inc momentum entries
  • The first momentum investment strategy would give 15.53% of return on Nuvasive Inc. That represents 815.09$ of latent gain with 5248.27$ of employed capital.
  • The second momentum investment strategy would give 17.33% of return on Nuvasive Inc. That represents 513.19$ of latent gain with 2960.61$ of employed capital.
Performance at glance (1Q Momentum)

Performance

15.53 %

Latent gain

815.09 $

Invested capital

5248.27 $

Annualized return

7.68 %
Performance at glance (2Q Momentum)

Performance

17.33 %

Latent gain

513.19 $

Invested capital

2960.61 $

Annualized return

4.73 %

Momentum equity curve on Nuvasive Inc

The following chart shows the equity curve of the two momentum strategies applied to Nuvasive Inc:

Nuvasive Inc momentum equity

Note: the dividends potentially given by Nuvasive Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Nuvasive Inc

The following chart shows the employed capital evolution of the two momentum strategies on Nuvasive Inc since the beginning:

Nuvasive Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Nuvasive Inc

Buy the dip entry openings on Nuvasive Inc

Nuvasive Inc

The performance achieved by the robo-advisor on Nuvasive Inc is 16.44%. That represents 124.82$ of latent gain with 759.42$ of employed capital. The following chart shows Nuvasive Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Nuvasive Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

16.44 %

Latent gain

124.82 $

Invested capital

759.42 $

Annualized return

7.68 %

Equity curve of the strategy applied to Nuvasive Inc

The following chart shows the result of the investment strategy applied to Nuvasive Inc:

Nuvasive Inc

Note: the dividends potentially given by Nuvasive Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Nuvasive Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Nuvasive Inc:

Nuvasive Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Nuvasive Inc

In this section, I will compare the three previous investment strategies applied to Nuvasive Inc.

Equity curve comparison on Nuvasive Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Nuvasive Inc investment strategy comparison

Employed capital comparison on Nuvasive Inc

Nuvasive Inc investment comparison

Performance comparison on Nuvasive Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 8.29% 188.54$ 2274.7$ 2.0%
Momentum 1 quarter 15.53% 815.09$ 5248.27$ 3.98%
Momentum 2 quarters 17.33% 513.19$ 2960.61$ 4.73%
Non-directional 16.44% 124.82$ 759.42$ 7.68%
Annualized return comparison

Automatic investment

2.0 %

Momentum 1Q

4.73 %

Momentum 2Q

4.73 %

Non-directional

7.68 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Nuvasive Inc:

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

  • INFINITY L&T

  • Note: The algorithm computes the probability of correlation between Nuvasive Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Nuvasive Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Nuvasive Inc
    Country United States
    City San Diego
    Address 7475 Lusk Boulevard
    Phone 858 909 1800
    Website www.nuvasive.com
    FullTime employees 2900
    Industry Medical Devices
    Sector Healthcare
    Exchange XNAS
    Ticker NUVA
    Market www.nasdaq.com

    Nuvasive Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown